New Year Bumper Sale @ Rs. 1 X
Meganeuron NT 75 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Meganeuron NT 75 Tablet safe for pregnant women?
Meganeuron NT can have harmful effects in pregnant women. If you experience any discomfort after using Meganeuron NT, then discontinue the use and take your doctor's advice.
Is the use of Meganeuron NT 75 Tablet safe during breastfeeding?
Taking Meganeuron NT may lead to serious side effects if you are breastfeeding. Meganeuron NT should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Meganeuron NT 75 Tablet on the Kidneys?
Meganeuron NT rarely affects the kidneys.
What is the effect of Meganeuron NT 75 Tablet on the Liver?
Using Meganeuron NT does not have any harmful effects on the liver.
What is the effect of Meganeuron NT 75 Tablet on the Heart?
Meganeuron NT is not harmful for the heart.
Meganeuron NT 75 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Meganeuron NT 75 Tablet unless your doctor advises you to do so -
Is this Meganeuron NT 75 Tablet habit forming or addictive?
Meganeuron NT 75 Tablet does not cause addiction.
Interaction between Food and Meganeuron NT 75 Tablet
You can take Meganeuron NT 75 Tablet with food.
Interaction between Alcohol and Meganeuron NT 75 Tablet
Taking Meganeuron NT 75 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420